Suppr超能文献

罗格列酮暴露的新生大鼠心肌细胞中的发育和细胞外基质重塑过程。

Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes.

机构信息

Department of Biology, San Diego State University, CA, USA.

出版信息

Pharmacogenomics. 2014 Apr;15(6):759-74. doi: 10.2217/pgs.14.39.

Abstract

OBJECTIVE

The objective of this study was to investigate the effects of rosiglitazone (Avandia(®)) on gene expression in neonatal rat ventricular myocytes.

MATERIALS & METHODS: Myocytes were exposed to rosiglitazone ex vivo. The two factors examined in the experiment were drug exposure (rosiglitazone and dimethyl sulfoxide vs dimethyl sulfoxide), and length of exposure to drug (½ h, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 18 h, 24 h, 36 h and 48 h).

RESULTS

Transcripts that were consistently expressed in response to the drug were identified. Cardiovascular system development, extracellular matrix and immune response are represented prominently among the significantly modified gene ontology terms.

CONCLUSION

Hmgcs2, Angptl4, Cpt1a, Cyp1b1, Ech1 and Nqo1 mRNAs were strongly upregulated in cells exposed to rosiglitazone. Enrichment of transcripts involved in cardiac muscle cell differentiation and the extracellular matrix provides a panel of biomarkers for further analysis in the context of adverse cardiac outcomes in humans. Original submitted 15 November 2013; Revision submitted 14 February 2014.

摘要

目的

本研究旨在探讨罗格列酮(文迪雅(®))对新生大鼠心室肌细胞基因表达的影响。

材料与方法

将心肌细胞进行离体暴露实验。实验中检查了两个因素,即药物暴露(罗格列酮和二甲基亚砜与二甲基亚砜)和药物暴露时间(½ h、1 h、2 h、4 h、6 h、8 h、12 h、18 h、24 h、36 h 和 48 h)。

结果

鉴定出对药物有一致反应的转录本。心血管系统发育、细胞外基质和免疫反应在显著改变的基因本体术语中表现突出。

结论

暴露于罗格列酮的细胞中 Hmgcs2、Angptl4、Cpt1a、Cyp1b1、Ech1 和 Nqo1 mRNA 强烈上调。涉及心肌细胞分化和细胞外基质的转录本的富集为进一步分析人类不良心脏结局提供了一组生物标志物。原始提交日期为 2013 年 11 月 15 日;修订后提交日期为 2014 年 2 月 14 日。

相似文献

2
The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysis.
Pharmacogenomics. 2019 Nov;20(16):1125-1141. doi: 10.2217/pgs-2019-0077.
7
Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes.
Toxicol Lett. 2017 Oct 5;280:151-158. doi: 10.1016/j.toxlet.2017.08.011. Epub 2017 Aug 16.
8
Exposure to rosiglitazone, a PPAR-γ agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus.
Am J Physiol Regul Integr Comp Physiol. 2014 Mar 15;306(6):R429-37. doi: 10.1152/ajpregu.00431.2013. Epub 2014 Jan 29.
10
Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non-hypertensive diabetic rats (PPAR γ).
J Diabetes. 2015 Jan;7(1):85-94. doi: 10.1111/1753-0407.12140. Epub 2014 Mar 27.

引用本文的文献

2
DNA Tension Probes Show that Cardiomyocyte Maturation Is Sensitive to the Piconewton Traction Forces Transmitted by Integrins.
ACS Nano. 2022 Apr 26;16(4):5335-5348. doi: 10.1021/acsnano.1c04303. Epub 2022 Mar 24.
5
The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysis.
Pharmacogenomics. 2019 Nov;20(16):1125-1141. doi: 10.2217/pgs-2019-0077.
6
Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.
Cell Stem Cell. 2016 Sep 1;19(3):311-25. doi: 10.1016/j.stem.2016.07.006. Epub 2016 Aug 18.
7
Systems analysis of the prostate transcriptome in African-American men compared with European-American men.
Pharmacogenomics. 2016 Jul;17(10):1129-1143. doi: 10.2217/pgs-2016-0025. Epub 2016 Jun 30.

本文引用的文献

1
ADAMTS7: a promising new therapeutic target in coronary heart disease.
Expert Opin Ther Targets. 2013 Aug;17(8):863-7. doi: 10.1517/14728222.2013.816287. Epub 2013 Jul 6.
2
Ocular disease, knowledge and technology applications in patients with diabetes.
Am J Med Sci. 2013 Apr;345(4):266-270. doi: 10.1097/MAJ.0b013e31828aa6fb.
3
Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes.
Diabetes Technol Ther. 2012 Jun;14 Suppl 1:S33-42. doi: 10.1089/dia.2012.0007.
4
Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication.
Circulation. 2012 Mar 27;125(12):1551-62. doi: 10.1161/CIRCULATIONAHA.111.066712.
5
BMPR1A is a candidate gene for congenital heart defects associated with the recurrent 10q22q23 deletion syndrome.
Eur J Med Genet. 2012 Jan;55(1):12-6. doi: 10.1016/j.ejmg.2011.10.003. Epub 2011 Oct 20.
6
Cardiomyopathy in α-kinase 3 (ALPK3)-deficient mice.
Vet Pathol. 2012 Jan;49(1):131-41. doi: 10.1177/0300985811402841. Epub 2011 Mar 25.
7
Homeodomain only protein x is down-regulated in human heart failure.
J Mol Cell Cardiol. 2011 Jun;50(6):1056-8. doi: 10.1016/j.yjmcc.2011.02.015. Epub 2011 Mar 5.
9
Rosiglitazone: a European regulatory perspective.
Diabetologia. 2011 Feb;54(2):213-8. doi: 10.1007/s00125-010-1992-5. Epub 2010 Dec 14.
10
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
Cardiovasc Res. 2011 Feb 1;89(2):265-72. doi: 10.1093/cvr/cvq308. Epub 2010 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验